Rich DeNunzio is the Chief Commercial Officer (CCO) at Click Therapeutics, where he oversees Market Access & Public Affairs, Commercial Excellence, New Product Planning, and Commercial Partnership Success, as well as Program Operations to drive the development of prescription digital therapeutics. With a background in pricing, marketing, finance, and market access, Rich has spent his career shaping strategies that improve patient access to innovative treatments. Prior to joining Click, he held various commercial leadership roles at Novo Nordisk, most recently serving as Vice President of Market Access, where he led Strategy & Innovation and National Accounts. Rich believes in the power that digital therapeutics can bring to support patient outcomes and wants to put his experience to work to benefit as many patients as possible.
Beyond his experience in pharmaceuticals, Rich has a strong background in finance and investments. He began his career on Wall Street, including time at the New York Stock Exchange, before transitioning to private equity, where he focused on deal evaluation and operational excellence.
Follow on: